|
| Revenues | 18,709.9 | 105.4 | Profits | -4,490.0 | -291.1 | Assets | 104,326.9 | -- | Stockholders' Equity | 48,352.9 | -- | Industry: Pharmaceuticals |
1 | Pfizer | 75 | 52,921 | 2 | Johnson & Johnson | 88 | 47,348 | 3 | GlaxoSmithKline | 122 | 37,304 | 4 | Novartis | 186 | 28,247 | 5 | Roche Group | 209 | 25,166 | 6 | Merck | 239 | 22,939 | 7 | Bristol-Myers Squibb | 258 | 21,886 | 8 | AstraZeneca | 267 | 21,426 | 9 | Abbott Laboratories | 285 | 20,473 | 10 | Sanofi-Aventis | 321 | 18,710 | 11 | Wyeth | 346 | 17,358 | 12 | Eli Lilly | 445 | 13,858 | From the July 25, 2005 issue | |